201 results
Page 5 of 11
6-K
EX-99.1
2wmvr50a4gl3ww6li1x6
20 Oct 22
Publication of 2022 financial statements
6:00am
6-K
EX-99.1
zllmt0
23 Sep 22
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
8fli7srdpq6vej
15 Sep 22
Innate Pharma Reports First Half 2022 Financial Results and Business Update
6:12am
6-K
EX-99.2
v2i7 sniz
15 Sep 22
Innate Pharma Reports First Half 2022 Financial Results and Business Update
6:12am
6-K
EX-99.1
310gx7na5pmmv
8 Sep 22
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
mh8og2d
6 Sep 22
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
men5apr qr60olo2v
23 Aug 22
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
z0v2m4u8ui0q3
17 Aug 22
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
2blh0zgxt1
1 Aug 22
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
c5h0m
28 Jul 22
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
1zqj3 r21tkc
21 Jul 22
Innate Pharma S.a. 6-K
6:01am
6-K
EX-99.1
iybjold
23 Jun 22
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
uwx5xcycdo6n4
3 Jun 22
Anti-CD39 monoclonal antibody IPH5201 advances to Phase 2 study in lung cancerInnate to receive $5M milestone payment from AstraZeneca
6:00am
6-K
EX-99.1
kv938ta6gwatx
20 May 22
Appointment of Dr Sally Bennett to the Supervisory Board
4:09pm
6-K
EX-99.1
55agat8zfgg5p40zzpj6
11 May 22
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
mik1s
10 May 22
Innate Pharma S.a. 6-K
6:05am
6-K
EX-99.1
ppee hn40z0
10 May 22
Innate Pharma S.a. 6-K
6:04am
6-K
EX-99.1
8e9kbd0ecd
3 May 22
Innate Pharma S.a. 6-K
5:37pm
424B5
izje6o2kwdcbxf96 bxm
3 May 22
Prospectus supplement for primary offering
4:36pm
6-K
EX-99.1
3xjhau8rwvqcui8sz3
3 May 22
Current report (foreign)
4:35pm